Storti, P <br/><br/>
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.  [electronic resource] 

 -  Leukemia  12 2016 
 - 2351-2363 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2016.137  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Hypoxia<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Galectin 1--antagonists & inhibitors<br/>Humans<br/>Mice<br/>Multiple Myeloma--blood supply<br/>Neovascularization, Pathologic--drug therapy<br/>RNA, Small Interfering--pharmacology<br/>Transfection<br/>Tumor Burden--drug effects